Allergy Meds Recalled for Ranitidine Risk | Savannah News

A major recall is underway for four batches of cetirizine hydrochloride tablets after they were found potentially contaminated with ranitidine — a drug linked to serious allergic reactions, including anaphylaxis. The issue was spotted by a pharmacy tech who noticed odd discoloration and red dots on the tablets, which were distributed nationwide by Rising Pharma Holdings. Affected lots — GY825029, GY825030, GY825031, and GY825032 — expire in October 2028. While no illnesses have been reported yet, the recall is voluntary and proactive to ensure safety. Consumers who purchased the products have been contacted via email for returns. For questions, contact Rising Pharma Holdings by phone or email. This incident echoes the 2020 ranitidine recall over NDMA concerns — reminding us how crucial it is to stay vigilant about what’s in our medications. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/624933783966829e